BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38367651)

  • 21. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [
    Tissot C; Servaes S; Lussier FZ; Ferrari-Souza JP; Therriault J; Ferreira PCL; Bezgin G; Bellaver B; Leffa DT; Mathotaarachchi SS; Chamoun M; Stevenson J; Rahmouni N; Kang MS; Pallen V; Margherita-Poltronetti N; Wang YT; Fernandez-Arias J; Benedet AL; Zimmer ER; Soucy JP; Tudorascu DL; Cohen AD; Sharp M; Gauthier S; Massarweh G; Lopresti B; Klunk WE; Baker SL; Villemagne VL; Rosa-Neto P; Pascoal TA
    J Nucl Med; 2023 Mar; 64(3):452-459. PubMed ID: 36396455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracer-specific reference tissues selection improves detection of
    Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y;
    Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease.
    Flores S; Chen CD; Su Y; Dincer A; Keefe SJ; McKay NS; Paulick AM; Perez-Carrillo GG; Wang L; Hornbeck RC; Goyal M; Vlassenko A; Schwarz S; Nickels ML; Wong DF; Tu Z; McConathy JE; Morris JC; Benzinger TLS; Gordon BA
    J Nucl Med; 2023 Feb; 64(2):287-293. PubMed ID: 35953305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal [
    Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
    Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of amyloid beta and tau PET without a structural MRI.
    Landau SM; Ward TJ; Murphy A; Iaccarino L; Harrison TM; La Joie R; Baker S; Koeppe RA; Jagust WJ;
    Alzheimers Dement; 2023 Feb; 19(2):444-455. PubMed ID: 35429219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Off-Target Binding on
    Baker SL; Harrison TM; Maass A; La Joie R; Jagust WJ
    J Nucl Med; 2019 Oct; 60(10):1444-1451. PubMed ID: 30877180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer's disease? A 2-year longitudinal study.
    Lagarde J; Olivieri P; Tonietto M; Rodrigo S; Gervais P; Caillé F; Moussion M; Bottlaender M; Sarazin M
    Alzheimers Res Ther; 2023 May; 15(1):91. PubMed ID: 37138309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.
    Lee CM; Jacobs HIL; Marquié M; Becker JA; Andrea NV; Jin DS; Schultz AP; Frosch MP; Gómez-Isla T; Sperling RA; Johnson KA
    J Alzheimers Dis; 2018; 62(4):1691-1702. PubMed ID: 29614677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced [
    Moscoso A; Grothe MJ; Schöll M;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in off-target binding using tau positron emission tomography.
    Smith R; Strandberg O; Leuzy A; Betthauser TJ; Johnson SC; Pereira JB; Hansson O
    Neuroimage Clin; 2021; 31():102708. PubMed ID: 34091353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease.
    Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T;
    Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
    Mundada NS; Rojas JC; Vandevrede L; Thijssen EH; Iaccarino L; Okoye OC; Shankar R; Soleimani-Meigooni DN; Lago AL; Miller BL; Teunissen CE; Heuer H; Rosen HJ; Dage JL; Jagust WJ; Rabinovici GD; Boxer AL; La Joie R
    Alzheimers Res Ther; 2023 Sep; 15(1):157. PubMed ID: 37740209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of
    Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
    Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.